Skip to content

To Study the Effect of certain Ayurvedic Formulations on Menstrual Irregularities.

The Combined Efficacy of Patha-Trikantaka- Vrikshaka Kwatha, Shatapushpa Choorna and Sukumara Ghrita in the Management of Lean PCOD- A Single-arm, Open label Clinical Study.

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/103144
Enrollment
30
Registered
2026-02-05
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E282- Polycystic ovarian syndrome

Interventions

None listed

Sponsors

DR ANAGHA R
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: BMI Less than 23 Kg per square metre Diagnosed with PCOD based on Rotterdam Criteria (Presence of any two of the following) 1. Biochemical or clinical Hyperandrogenism 2. Ultrasonographic appearance of Polycystic ovaries with exclusion of other relevant disorders 3. Evidence of oligo or anovulation Patients willing to sign the consent form (parent consent if age is less than 18 years)

Exclusion criteria

Exclusion criteria: Pelvic or systemic diseases causing oligomenorrhea and anovulation Organic lesions of reproductive tract like TB, Carcinoma and congenital deformities Patients suffering from other disorders like fibroid uterus, pelvic inflammatory disease, endometriosis and STDs Patients suffering from uncontrolled Diabetes, Hypertension or Thyroid dysfunctions Pregnant and lactating women

Design outcomes

Primary

MeasureTime frame
To evaluate the combined efficacy of Patha-Trikantaka-Vrikshaka kwatha, Shatapushpa Choorna and Sukumara Ghrita in regulating menstrual irregularities and enhancing follicular development and ovulation in women with PCOD.Timepoint: 3 months for intervention 1 month for follow-up Total study duration - 4 months

Secondary

MeasureTime frame
To document any adverse effects or tolerability issues associated with the regimen. To assess the Quality of Life with special reference to Manasika bhavas.Timepoint: 3 months for intervention 1 month for follow-up

Countries

India

Contacts

Public ContactDR MAMATHA KV

Sri Dharmasthala Manjunatheshwara college of ayurveda hospital and research centre.Udupi

mamath2@gmail.com9448215605

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026